Skip to main content

Advertisement

Log in

Genistein Inhibits Aβ25–35-Induced Synaptic Toxicity and Regulates CaMKII/CREB Pathway in SH-SY5Y Cells

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Genistein (Gen), as a functional food in human diet, has shown many beneficial effects on neurodegenerative diseases such as Alzheimer’s disease (AD). But the neuroprotective mechanism of Gen is not clear. Because synaptic failure is considered as the earliest phase in the pathogenesis of AD, we try to validate our hypothesis that synapse may be one target of Gen on protecting neurons. In this study, SH-SY5Y cells were pre-incubated with or without Gen for 2 h followed by the incubation with Aβ25–35 (25 μmol/L) for another 24 h. Flow cytometry, Western Blots, and RT-PCR analysis were used to test the synaptic factors. The data showed that Gen pre-treatment could reverse the Aβ25–35-induced down-regulation of synaptophysin and postsynaptic marker postsynaptic density-95. In addition, the down-regulation of NR1 and NR2B induced by Aβ25-35 which are subunits of N-methyl-d-aspartate receptor also could be antagonized by pre-treatment of Gen. Moreover, the factors of CaMKII/CREB signaling pathway were detected. The results showed that mRNA and protein expressions of (Ca2+)/calmodulin(CaM), CaMKII/pCaMKII, and CREB/pCREB were significantly down-regulated by Aβ25–35, but they were all restored by the pre-treatment of Gen. Furthermore, Gen also maintained the intracellular Ca2+ concentration which was disturbed by Aβ25–35. In conclusion, these results suggested that Gen could protect synaptic dysfunction induced by Aβ, and the mechanism might be associated with the regulation of synaptic markers and Ca2+ level through activating CaM/CaMK/CREB signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

Aβ:

β-Amyloid peptides

AD:

Alzheimer’s disease

SYN:

Synaptophysin

PSD-95:

Postsynaptic density-95

NMDAR:

N-Methyl-d-aspartate receptor

CaM:

Calmodulin

CaMKII:

Ca2+/calmodulin-dependent protein kinase II

CREB:

cAMP response element binding protein

References

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China (Nos. 81172661, 81302427 and 81330065), National High Technology Research and Development Program (863 Program) of China (No. 2010AA023003).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rong Xiao.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Additional information

Yuan-Di Xi and Dan-Di Zhang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xi, YD., Zhang, DD., Ding, J. et al. Genistein Inhibits Aβ25–35-Induced Synaptic Toxicity and Regulates CaMKII/CREB Pathway in SH-SY5Y Cells. Cell Mol Neurobiol 36, 1151–1159 (2016). https://doi.org/10.1007/s10571-015-0311-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-015-0311-6

Keywords

Navigation